30 years guarding hearts: Sergei Reutov awarded for his contribution to the development of domestic pacemakers

30 years guarding hearts: Sergei Reutov awarded for his contribution to the development of domestic pacemakers

08.08.2025 y.

Sergey Reutov, Deputy General Director for Production at Cardioelectronics (part of the Rostec State Corporation), was awarded the Certificate of Honor of the Ministry of Industry and Trade of the Russian Federation. The award was presented for his significant contribution, outstanding achievements in industrial development, and many years of dedicated service.

Sergey Reutov has dedicated 30 years to the development of medical devices for cardiology. His career path took him from a technician-technologist at the Klimovsky Stamping Plant to Deputy General Director for Production..

Under his leadership, approximately 120,000 pacemakers were manufactured, bringing hope to patients with cardiac arrhythmias. Beginning his career in the pacemaker production workshop and later heading the company's technical bureau, he always demonstrated high professionalism and dedication. This enabled the implementation of numerous innovative technical solutions. He was directly involved in the development of the first domestically produced MRI-compatible pacemaker, the Apollo MRI.

«The production of pacemakers is not just a labor-intensive technological process. It is a contribution to the nation's health. Without our devices, many patients would be at risk of sudden cardiac arrest and serious complications. I am glad that my profession combines medicine and technology to save people's lives. I thank the Ministry of Industry and Trade for this high recognition of our work, and my colleagues for their support and professionalism. This award is a credit to the entire team», — said Sergey Reutov.

Kardioelektronika is the only Russian manufacturer of MRI-compatible pacemakers and electrodes, offering in-demand solutions for modern cardiology. Today, the company supplies its products to almost all regions of the country—from Kaliningrad to Kamchatka. The company's devices are used to treat patients in more than 100 leading scientific and medical centers, including the A.N. Bakulev National Medical Research Center for Cardiovascular Surgery, the A.V. Vishnevsky National Medical Research Center of Surgery, and the M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI). This demonstrates a high level of trust in the quality and effectiveness of the device.